Real-Life Active Surveillance of a Naphazoline/ Hypromellose Fixed Combination’s Safety Profile in Peruvian Population

OBJECTIVE: Identifying the adverse reactions and the possible risks associated with the use of naphazoline 0.1% + hypromellose 0.5% (NAPH), thereby evaluating its tolerability and safety profile. METHODS: A total of 236 Peruvian patients were included in an active pharmacovigilance study drug event...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras-Salinas, Homero, Barajas-Hernández, Mariana, Baiza-Durán, Leopoldo Martín, Orozco-Ceja, Vanessa, Rodríguez-Herrera, Lourdes Yolotzin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528543/
https://www.ncbi.nlm.nih.gov/pubmed/34703789
http://dx.doi.org/10.2147/IPRP.S332421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528543/
https://www.ncbi.nlm.nih.gov/pubmed/34703789
http://dx.doi.org/10.2147/IPRP.S332421

Ejemplares similares